STORIES
RECENT ARTICLES
Ruya Ventures Raises €43 Million for Its First DeepTech VC Fund
Ruya Ventures, a London-based venture capital firm founded by DeepTech investor Rick Hao, has raised €43 million ($50 million) for its first venture capital fund. The new fund will invest in DeepTech startups around the world, helping them turn research and laboratory innovations into real-world products and businesses. Read Also- Biotech Startup Telum Therapeutics Raises […]
July 1, 2026
Biotech Startup Telum Therapeutics Raises €18 Mn in Series A Round
Spanish biotech startup Telum Therapeutics has raised €18 million in a Series A funding round. The round was led by the AMR Action Fund, with participation from new investor Inveready and continued support from existing investors Invivo Partners, CDTI (through SICC Innvierte), Clave Capital, and Sodena. Read Also- Rezon Bio Appoints Dr. Hubert Scholze as […]
July 1, 2026
Rezon Bio Appoints Dr. Hubert Scholze as Chief Business Officer
European biologics CDMO Rezon Bio has appointed Dr. Hubert Scholze as its new Chief Business Officer (CBO), effective July 1, 2026. As part of Rezon Bio’s Executive Leadership Team, Dr. Scholze will lead the company’s business development, marketing, market intelligence, proposal management, and project management teams. He will also oversee the company’s commercial strategy, build […]
July 1, 2026
Personar Appoints Mike Slade as Senior Advisor to Support Global Growth
Personar Ltd, the AI sports audio intelligence company behind TrackSwift and CoachScribe, has appointed Mike Slade as its Senior Advisor. Slade has more than 40 years of experience in technology, media, and sports. He will advise Personar’s leadership team on strategy, product development, and global growth as the company expands its business in elite sports. […]
July 1, 2026
EquiLibre Technologies Raises Series A Round led by Creandum
Prague-based EquiLibre Technologies, an AI trading research company, has raised an undisclosed amount in Series A funding at a valuation of more than €438 million ($500 million). The funding round was led by Creandum and is reportedly the firm’s largest investment so far. The company will use most of the funding to buy more computing […]
July 1, 2026
Industry Insights
RECENT ARTICLES
Syngenta Group Appoints Hengde Qin as Chief Executive Officer
Syngenta Group has announced that it’s Board of Directors has unanimously appointed Hengde Qin as Chief Executive Officer, effective August 1, 2026, following a formal nomination, and succession process. Qin, who currently serves as Chief Operating Officer and Head of Seeds, will succeed Jeff Rowe. Rowe will remain in the role until August 1 before […]
July 1, 2026
Build Raises €7.4 million in Seed Funding Led by Index Ventures
Build, a San Francisco, CA-based developer of an AI-native infrastructure and automated real estate development platform, has raised €7.4 million in a seed funding round led by Index Ventures. The round also saw participation from Pebblebed, Puzzle Ventures, Tiny.vc, and tech executives including OpenAI CFO Sarah Friar and Blackstone CTO John Stecher. The company plans […]
July 1, 2026
Markel Insurance appoints Bhavik Desai as Managing Director
Markel Insurance, the insurance business of Markel Group Inc., has appointed Bhavik Desai as Managing Director of Professional and Financial Risks (PFR) & Cyber for its London Market business. In this role, Desai will oversee underwriting strategy, portfolio performance, and relationships with brokers and clients. He will help drive disciplined underwriting, technical expertise and long […]
July 1, 2026
Centrifuge and New York Life Investment Management Partner
Centrifuge has partnered with New York Life Investment Management (NYLIM), one of the world’s largest active asset managers with about $807 billion in assets under management (AUM), to launch the NYLIM Anemoy U.S. High Yield Corporate Bond Segregated Portfolio (ticker: HYB). The launch marks NYLIM’s first tokenized investment product, giving investors digital access to the […]
July 1, 2026
Caidya Announces Strategic Combination with Simbec-Orion
Caidya has announced a strategic combination with Simbec-Orion to better connect early-stage research with global clinical trial execution. Together, the two companies will create a specialized clinical contract research organization (CRO) that helps biopharma companies run clinical programs with greater speed, focus, and accountability. The combination brings together the strengths of both companies to provide […]
July 1, 2026





































